OptiBiotix Health PLCOptiBiotix Health PLCOptiBiotix Health PLC

OptiBiotix Health PLC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪12.24 M‬EUR
−0.0016EUR
‪−2.18 M‬EUR
‪1.05 M‬EUR
‪87.39 M‬
Beta (1Y)
0.91

About OptiBiotix Health PLC


CEO
Stephen Patrick O'Hara
Headquarters
Heslington
Founded
2006
ISIN
GB00BP0RTP38
FIGI
BBG00F9Z8NL7
Optibiotix Health Plc engages in the research and development of compounds that modify the human microbiome. Its products include SlimBiome, LPLDL, CholBiome, SweetBiotix, LPGOS, and WellBiome. The company was founded by Stephen Patrick O'Hara on June 19, 2006, and is headquartered in Heslington, the United Kingdom.

Check out other big names from the same industry as OB3.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange OptiBiotix Health PLC stocks are traded under the ticker OB3.
OB3 reached its all-time high on Aug 9, 2018 with the price of 1.3950 EUR, and its all-time low was 0.0610 EUR and was reached on Jun 28, 2023. View more price dynamics on OB3 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track OptiBiotix Health PLC financials in yearly and quarterly reports right on TradingView.
OptiBiotix Health PLC is going to release the next earnings report on Jun 25, 2026. Keep track of upcoming events with our Earnings Calendar.
OB3 net income for the last half-year is ‪−1.37 M‬ EUR, while the previous report showed ‪1.19 M‬ EUR of net income which accounts for −215.11% change. Track more OptiBiotix Health PLC financial stats to get the full picture.
No, OB3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OptiBiotix Health PLC EBITDA is ‪−2.83 M‬ EUR, and current EBITDA margin is −237.36%. See more stats in OptiBiotix Health PLC financial statements.
Like other stocks, OB3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OptiBiotix Health PLC stock right from TradingView charts — choose your broker and connect to your account.